TY  - JOUR
AU  - Tejada Cifuentes, Francisco
AU  - Lloret Callejo, Ángeles
AU  - Tirado Peláez, María José
AU  - Rubio Pulido, Olga
AU  - Ruiz-Morote Aragón, Marta
AU  - Fernández Urrusuno, Rocío
AU  - Muñoz Carreras, María Isabel
AU  - Méndez Esteban, María Isabel
AU  - Maestre Sánchez, Victoria
AU  - García Bonilla, Antonio
AU  - Paredero Dominguez, José Manuel
AU  - Arroyo Pineda, Virginia
AU  - Marco Tejón, Esther
AU  - Romero Candel, Gregorio
AU  - Fernández Marchante, Ana Isabel
AU  - Marco Del Rio, José
AU  - Ortiz Martín, Teresa
AU  - López Sánchez, Piedad
PY  - 2020
DO  - 10.1016/j.medcli.2020.10.006
UR  - http://hdl.handle.net/10668/16780
T2  - Medicina clinica
AB  - To analyze the incidence of Covid-19 in patients who are chronic users of hydroxychloroquine. Cross-sectional retrospective observational multicenter study in health areas and districts from Castilla La-Mancha and Andalucia. Of the 4451 participants...
LA  - en
KW  - COVID-19
KW  - Coronavirus
KW  - Hidroxicloroquina
KW  - Hydroxychloroquine
KW  - Incidence
KW  - Incidencia
KW  - Tratamiento
KW  - Treatment
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Antirheumatic Agents
KW  - Arthritis, Rheumatoid
KW  - COVID-19
KW  - COVID-19 Testing
KW  - Chronic Disease
KW  - Cross-Sectional Studies
KW  - Female
KW  - Humans
KW  - Hydroxychloroquine
KW  - Incidence
KW  - Lupus Erythematosus, Systemic
KW  - Male
KW  - Middle Aged
KW  - Prognosis
KW  - Protective Factors
KW  - Retrospective Studies
KW  - Risk Factors
KW  - Spain
TI  - Incidence of COVID-19 in patients under chronic treatment with hydroxychloroquine.
T2  - Incidencia de la COVID-19 en pacientes en tratamiento crónico con hidroxicloroquina.
TY  - research article
VL  - 156
ER  -